AKT1 and gastric cancer: Studies have shown that targeting Cytosolic phospholipase A2 (cPLA2α) inhibits GC and enhances chemotherapy efficacy by suppressing the Ras/MAPK kinase/extracellular signal-regulated kinase and Akt/β-catenin pathways [59].